12/04/2023Information
12/01/2023Sustainability
Participation in New Energy Collaborative
11/30/2023Corporate
JSR at SEMICON JAPAN 2023
11/17/2023Sustainability
JSR Group Releases its “JSR Group Sustainability Site 2023”
11/09/2023Products
MEBGEN™ BRAF 3 Kit Receives MHLW Approval and Insurance Coverage as a Tumor Agnostic Companion Diagnostic
11/08/2023Products
Crown Bioscience Introduces OrganoidXplore: Revolutionizing Cancer Research with Rapid Large-scale Organoid Drug Screening
10/11/2023Corporate
Annual Report 2023 is now Available
09/13/2023Products
KBI Biopharma, Inc. Expands Global Portfolio with Launch of SUREmAb™ for Faster Monoclonal Antibody Development and Manufacturing ~ Offering extends legacy of SUREtechnology Platform™ for more efficient workflows and simplified processes ~
09/12/2023Corporate
Indivumed Services’ Hamburg Site Receives College of American Pathologists (CAP) Accreditation
08/24/2023Corporate
A collaborative work between Crown Bioscience and HanX Biopharma published in Nature's Scientific Reports
08/07/2023Information
Eric Johnson, CEO and President, has been elected to the board of SEMI
07/06/2023Corporate
JSR Active Innovation Fund LLC invests in Gaianixx Inc., which develops single-crystal films for semiconductors
06/19/2023Corporate
JSR Partners with Hokkaido University for Production and Sales of Functional Lipids for Lipid Nanoparticle DDS
06/19/2023Corporate
MBL hold ribbon cutting of a new R&D facility for Cell Therapy in Beijing, China.
06/06/2023Products
KBI Biopharma Unveils KBI PUREplatform™, a Game-Changing Microbial Expression Offering to Redefine Biopharmaceutical Manufacturing
06/01/2023Corporate
Announcement of Operational Consolidation of KBI Biopharma, Inc. and Selexis SA
05/29/2023Corporate
JSR's interfacial molecular binder "MOLTIGHT IMB" won "The 19th JPCA Award" !
05/24/2023Information
Beware of False Job Postings
04/18/2023Corporate
KBI Biopharma and Selexis SA Appoint J.D. Mowery as CEO
04/05/2023Corporate
Crown Bioscience completes acquisition of IndivuServ business unit of Indivumed GmbH
04/03/2023Corporate
JSR begins development of raw materials from biomass Concluded a joint development agreement with Bacchus Bio innovation Co., Ltd.
03/22/2023Products
KBI Biopharma, Inc. Releases Inaugural FIH Manufacturing Batch at Integrated Switzerland Facility
03/15/2023Products
FLOSFIA and JSR progress toward practical use of the world's first P-type semiconductor, Iridium Gallium Oxide -- Development of new iridium-based film formation materials for mass production creates a solution for realizing the ultimate SEMI ecology™ -
03/10/2023Corporate
Crown Bioscience opens new lab in Singapore, sets up commercial partners there
03/01/2023Sustainability
Support for the people and areas affected by the Turkey-Syria Earthquake
02/16/2023Corporate
JSR is introduced on IBM Quantum case studies
02/15/2023Corporate
This Rare Metal Could Produce Large Spin Current
02/15/2023Products
JSR Life Sciences, LLC entered into a subcontract with Novel351k to co-develop biosimilar programs
02/01/2023Corporate
JSR Received the "2022 TSMC Excellent Performance Awards" from TSMC
02/01/2023Products
JSR Withdraws from Agency Contract with Carbon 3D Printing Business
01/26/2023Corporate
Crown Bioscience to Acquire Indivumed’s Service Business and Supporting Biobank
01/25/2023Products
KBI Biopharma Announces Subcontract with Mapp Biopharmaceutical on Sudan ebolavirus Treatment
01/19/2023Products
JSR at INTER NEPCON JAPAN 2023
01/11/2023Corporate
Announcement regarding acquisition of JSR Electronic Materials Korea
01/01/2023Corporate